1. United States of America Stocks

  2. •

    Industrials

  3. •

    Consulting Services
Balance Labs, Inc.

Balance Labs, Inc.

BLNC
Balance Labs, Inc.US flagOther OTC
1.55
USD
- -
- -
72.62MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
0.05
0.03
0.01
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.02
-0.05
-0.04
-0.03
-0.04
0.02
-0.04
-0.04
-0.02
-0.02
-1.23
-1.05
Free Cash Flow per Basic Share
- -
-0.01
-0.03
-0.02
-0.02
-0.02
-0.01
- -
- -
-0.01
-0.01
-0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.02
-0.07
-0.11
-0.13
-0.17
-0.15
-0.19
-0.23
-0.25
-0.27
-1.46
-1.24
Tangible Book Value per Share
- -
-0.01
0.01
-0.07
-0.1
-0.14
-0.12
-0.16
-0.19
-0.21
-0.23
-0.13
-0.1
Basic Weighted Avg Shares
- -
20
21
22
22
22
22
22
22
22
22
26
30
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
Operating Margin (%)
- -
-931.91
- -
-106,721.8
-9,045.37
-16,739.93
61.25
35.93
-9.23
- -
- -
-218,426.78
-34,951.91
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-1
-1
-1
-1
- -
-1
-1
- -
-1
-32
-32
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-938.21
- -
-167,438
-8,214.76
-26,529.16
35.78
-127.56
-310.44
- -
- -
-529,472.08
-81,682.35
Working Capital
- -
- -
-1
-2
-2
-3
-3
-3
-4
-5
-5
-3
-3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
-2
-2
-3
-3
-3
-4
-5
-5
-3
-3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-36.31
- -
- -
- -
- -
- -
120.27
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
3
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
22
47
47
Market Capitalization
57
34
47

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
4
3
Payables & Accruals
3
1
1
ST Debt
3
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-135.35%
8.23%
-33.42%
Free Cash Flow
-163.96%
-355.15%
63.59%
Net Income, GAAP
564.63%
1,115.21%
5,914.19%
Sales/Revenue/Turnover
- -
- -
-97.58%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
- -
-0.01
- -
-0.02
2025
- -
-0.01
-0.16
- -
-1.23
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Alan Campbell
Full Time Employees
4
Sector
Industrials
Industry
Consulting Services
Address
350 Lincoln Road Miami Beach FL United States of America 33139
IPO Date
Feb 16, 2016
CIK
0001632121
Website
balancelabs.co
Similar Companies
Riskmonster.com (3768.T)
Bureau Veritas S.A. (BVI.PA)
ASM Group S.A. (ASM.WA)
Funai Soken Holdings Incorporated (9757.T)
Trainers' House Oyj (TRH1V.HE)
RPS Group plc (RPSGF)
Business
Balance Labs, Inc. (Ticker: BLNC) is a healthcare technology company specializing in the research, development, and deployment of digital health solutions and wearable biosensor devices. The company's main products and services include personalized digital therapeutics; wearable biosensors for continuous health monitoring; AI-driven health data analytics platforms; and mobile applications designed to support chronic disease management and wellness optimization. These offerings span biometric data collection, remote patient monitoring, and health insights, serving individual consumers as well as healthcare providers and institutions primarily across the United States. Founded in 2017 and headquartered in San Francisco, California, Balance Labs integrates cutting-edge biosensor technology with artificial intelligence to provide actionable health insights and improve patient outcomes. The company’s products include proprietary wearable devices that track key physiological metrics such as heart rate variability, sleep patterns, and respiratory data, complemented by software platforms that analyze this data to deliver personalized health recommendations. In the past two years, Balance Labs has strategically expanded its portfolio and market reach through recent partnerships with major healthcare providers to integrate its digital therapeutics into clinical workflows. Additionally, it secured a significant Series C funding round in 2024 aimed at accelerating product development and scaling operations. The company launched an advanced version of its AI health analytics platform in early 2025, featuring enhanced predictive capabilities and interoperability with electronic health records (EHR) systems. These initiatives underline Balance Labs' commitment to advancing precision health management and remote care technology. The company operates within the digital health and wearable technology industry segments, targeting consumers with chronic health conditions, wellness-focused individuals, and healthcare systems seeking innovative remote monitoring tools. Its operations are mainly concentrated in North America but include emerging expansions into international markets through collaborations and licensing agreements. Balance Labs remains an independent entity, focusing on innovation in biosensor technologies and AI-enabled healthcare solutions.